NEWS
Largest ever genomic dataset available for research
For the first time, genomic data for over 37,000 children and parents collected over multiple decades from across the UK are now available to researchers worldwide. High-resolution DNA sequencing has
created a unique resource to explore the relationship between genetic and environmental factors in child health and development. The data release is led by: Wellcome Sanger Institute; Children of the 90s (also known as ALSPAC); Millennium Cohort Study (MCS); and Born in Bradford (BiB). The data release is supported by the Economic and Social Research Council (ESRC) and Medical Research Council (MRC). Previously, large DNA sequence datasets typically focused on children with rare conditions or adult population cohorts. This new data release is the first time the focus has been on sequencing birth cohorts, which are population- based studies of people followed from birth through to adolescence or early adulthood.
These combined data resources offer the scientific community the opportunity to make valuable insights in areas ranging from population genetics to the social sciences. In the coming months, this DNA sequence data resource will be expanded to encompass all participants in these cohorts as well as additional cohorts. The value of these data will be enhanced by harmonising the data across the different cohorts, providing a more powerful resource than could be achieved by one study in isolation. Dr Richard Evans, Interim Head of Population Health Sciences at MRC, said: “The UK’s cohorts and longitudinal population studies are an extraordinary national asset, made possible by the participation of a diverse range of people. The rich data and samples from these studies, when combined with whole exome sequencing, can unlock new research questions and insights into human society, development, health and aging.” Now available on the European Genome-phenome Archive, these high- quality genomic data can be used in combination with the existing longitudinal health and survey information provided by participating families. The team has made the anonymised data as accessible as possible to approved researchers.
14
Health Minister’s MHRA visit marks Science Week
The Medicines and Healthcare products Regulatory Agency (MHRA) welcomed Health Minister Karin Smyth MP to its science campus recently as part of British Science Week to demonstrate how innovations become safe, effective treatments for NHS patients. As part of British Science Week and NHS Healthcare Science Week, the visit highlighted the MHRA’s role in driving life sciences innovation – helping UK patients benefit from cutting-edge technologies, from mRNA vaccines to advanced cancer diagnostics.
During the visit, Minister Smyth (pictured) met with MHRA scientists and regulatory experts to hear how their work is helping the NHS move towards earlier diagnosis and prevention. This includes making sure the annual flu vaccine is as effective as possible, setting safety standards for genomic cancer testing, and enabling rapid access to new treatments. The Minister toured MHRA biologics laboratories, where scientists rigorously test biological medicines, including vaccines,
to ensure they are effective and acceptably safe for patients. She also heard how the MHRA works with industry and healthcare partners to keep vital medicines available, so patients can access the treatments they need without delay.
Health Minister Karin Smyth MP said: “It was fantastic to see first-hand how MHRA’s scientists’ expertise is driving innovation, protecting patients, and strengthening our healthcare system. British Science Week is a great time to celebrate their achievements and the UK’s world-leading expertise in medical innovation.”
Una Health introduces QuikRead go Plus
Una Health has launched the QuikRead go Plus, the latest advancement in rapid diagnostic technology from Aidian, promising an upgraded user interface and enhanced connectivity. Available now from UK distributor Una Health, the QuikRead go Plus system builds upon the trusted performance of the QuikRead go, with the same fast, reliable, and easy-to-use diagnostic capabilities while introducing new features offering enhanced efficiency, accuracy, and connectivity to healthcare professionals across the country. This next- generation device is fully compatible with existing QuikRead go tests, ensuring a
smooth transition for current users. Key advancements with QuikRead go
Plus are: n Enhanced connectivity: with seamless integration into laboratory and patient record systems, QuikRead go Plus simplifies data management. The instrument can be connected to LIS/HIS systems with a LAN cable or through Wi-Fi.
n User-friendly design: an upgraded touchscreen interface and intuitive navigation make operation even more efficient, reducing training time for healthcare professionals.
n Reliable, fast results: continuing the legacy of QuikRead go, the new system delivers rapid, precise diagnostic results at the point of care, supporting timely clinical decisions.
n Optimised workflow: with improved software functionality, QuikRead go Plus enhances workflow efficiency, allowing healthcare providers to focus on patient care.
To find out more, visit Una Health online at
www.unahealth.co.uk.
APRIL 2025
WWW.PATHOLOGYINPRACTICE.COM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
